NYSE:STVN Stevanato Group (STVN) Stock Price, News & Analysis €21.99 -0.36 (-1.61%) As of 10:04 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Stevanato Group Stock (NYSE:STVN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stevanato Group alerts:Sign Up Key Stats Today's Range€21.28▼€22.8150-Day Range€17.90▼€23.0252-Week Range€16.56▼€33.49Volume2,895 shsAverage Volume341,533 shsMarket Capitalization$6.66 billionP/E Ratio46.79Dividend Yield0.27%Price TargetN/AConsensus RatingModerate Buy Company OverviewStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.Read More… Remove Ads Stevanato Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreSTVN MarketRank™: Stevanato Group scored higher than 33% of companies evaluated by MarketBeat, and ranked 749th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Stevanato Group.Read more about Stevanato Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth16.00% Earnings GrowthEarnings for Stevanato Group are expected to grow by 16.00% in the coming year, from €0.50 to €0.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stevanato Group is 47.53, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.58.Price to Earnings Ratio vs. SectorThe P/E ratio of Stevanato Group is 47.53, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.74.Price to Earnings Growth RatioStevanato Group has a PEG Ratio of 7.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStevanato Group has a P/B Ratio of 5.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.08% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 9.5.Change versus previous monthShort interest in Stevanato Group has recently decreased by 1.96%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldStevanato Group has a dividend yield of 0.27%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthStevanato Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Stevanato Group is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Stevanato Group will have a dividend payout ratio of 10.34% next year. This indicates that Stevanato Group will be able to sustain or increase its dividend.Read more about Stevanato Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.08% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 9.5.Change versus previous monthShort interest in Stevanato Group has recently decreased by 1.96%, indicating that investor sentiment is improving. News and Social Media3.4 / 5News Sentiment1.13 News SentimentStevanato Group has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Stevanato Group this week, compared to 2 articles on an average week.Search Interest1 people have searched for STVN on MarketBeat in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Stevanato Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.70% of the stock of Stevanato Group is held by insiders.Read more about Stevanato Group's insider trading history. Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Stock News HeadlinesS&P 500 Futures Decline in Premarket Trading; Smithfield Foods, Microchip Technology LagMarch 20, 2025 | marketwatch.comStevanato Group management to meet with StephensMarch 18, 2025 | markets.businessinsider.comDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.March 25, 2025 | Weiss Ratings (Ad)Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare ForumMarch 11, 2025 | businesswire.comStevanato Group S.p.A. (NYSE:STVN) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comStevanato: Ramping Syringe Demand, Buy ConfirmedMarch 9, 2025 | seekingalpha.comStevanato Group S.p.A. (STVN) Q4 2024 Earnings Call TranscriptMarch 8, 2025 | seekingalpha.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Fate Therapeutics (FATE) and Stevanato Group (STVN)March 6, 2025 | markets.businessinsider.comSee More Headlines STVN Stock Analysis - Frequently Asked Questions How have STVN shares performed this year? Stevanato Group's stock was trading at €21.79 at the beginning of 2025. Since then, STVN stock has increased by 2.5% and is now trading at €22.34. View the best growth stocks for 2025 here. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) released its quarterly earnings data on Thursday, March, 6th. The company reported $0.20 EPS for the quarter, meeting analysts' consensus estimates of $0.20. The business earned $352.68 million during the quarter, compared to analysts' expectations of $346.26 million. Stevanato Group had a trailing twelve-month return on equity of 9.86% and a net margin of 10.47%. When did Stevanato Group IPO? Stevanato Group (STVN) raised $720 million in an IPO on Friday, July 16th 2021. The company issued 32,000,000 shares at a price of $21.00-$24.00 per share. Who are Stevanato Group's major shareholders? Top institutional investors of Stevanato Group include Conestoga Capital Advisors LLC (2.67%), T. Rowe Price Investment Management Inc. (1.09%), TimesSquare Capital Management LLC (1.09%) and Thrivent Financial for Lutherans (0.92%). How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Stevanato Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Fortinet (FTNT), Antero Resources (AR), CrowdStrike (CRWD), Walt Disney (DIS) and Onsemi (ON). Company Calendar Last Earnings3/06/2025Today3/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:STVN CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees4,650Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.48 Trailing P/E Ratio47.53 Forward P/E Ratio44.68 P/E Growth7.18Net Income$157.62 million Net Margins10.47% Pretax Margin14.11% Return on Equity9.86% Return on Assets5.79% Debt Debt-to-Equity Ratio0.22 Current Ratio1.81 Quick Ratio1.21 Sales & Book Value Annual Sales$1.10 billion Price / Sales6.13 Cash Flow€0.93 per share Price / Cash Flow23.97 Book Value€4.15 per share Price / Book5.38Miscellaneous Outstanding Shares302,843,000Free Float300,723,000Market Cap$6.77 billion OptionableOptionable Beta0.60 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:STVN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.